Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$2.49B |
| 2 |
Alcon
ALC
|
+$805M |
| 3 |
Bank of America
BAC
|
+$662M |
| 4 |
RTN
Raytheon Company
RTN
|
+$621M |
| 5 |
Dow Inc
DOW
|
+$575M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.18B |
| 2 |
Wells Fargo
WFC
|
+$1.01B |
| 3 |
Qualcomm
QCOM
|
+$860M |
| 4 |
American Tower
AMT
|
+$688M |
| 5 |
Alibaba
BABA
|
+$651M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.08% |
| 2 | Financials | 14.73% |
| 3 | Technology | 14.09% |
| 4 | Industrials | 10.91% |
| 5 | Consumer Discretionary | 9.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Unity Bancorp
UNTY
$591M
| $13.9M | ﹤0.01% |
613,736
+14,304
| +2% | +$299K |
|
1102
Ubiquiti
UI
$33.7B
| $13.9M | ﹤0.01% |
105,907
+43,920
| +71% | +$6.36M |
|
1103
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
| $13.9M | ﹤0.01% |
122,520
-15,319
| -11% | -$1.69M |
|
1104
CorVel
CRVL
$3.06B
| $13.9M | ﹤0.01% |
477,597
-919,800
| -66% | -$22.6M |
|
1105
Textron
TXT
$14.7B
| $13.8M | ﹤0.01% |
260,856
-10,954
| -4% | -$555K |
|
|
CALA
1106
DELISTED
Calithera Biosciences, Inc
CALA
| $13.8M | ﹤0.01% |
177,134
-5,361
| -3% | -$608K |
|
1107
Newmont
NEM
$98.7B
| $13.8M | ﹤0.01% |
359,028
-391,639
| -52% | -$13.2M |
|
1108
Webster Financial
WBS
$12.5B
| $13.8M | ﹤0.01% |
288,895
-2,520
| -0.9% | -$126K |
|
1109
Cleveland-Cliffs
CLF
$6.57B
| $13.8M | ﹤0.01% |
1,293,171
+307,282
| +31% | +$3.03M |
|
1110
Ascendis Pharma A/S
ASND
$16B
| $13.8M | ﹤0.01% |
119,539
+9,962
| +9% | +$1.19M |
|
|
CBAY
1111
DELISTED
Cymabay Therapeutics
CBAY
| $13.7M | ﹤0.01% |
1,915,115
+101,125
| +6% | +$1.15M |
|
1112
UFP Technologies
UFPT
$1.97B
| $13.6M | ﹤0.01% |
327,719
-28,600
| -8% | -$1.08M |
|
1113
Cognizant
CTSH
$24.9B
| $13.6M | ﹤0.01% |
214,474
-1,359,914
| -86% | -$89.2M |
|
1114
Camtek
CAMT
$6.18B
| $13.5M | ﹤0.01% |
1,603,006
-57,500
| -3% | -$530K |
|
1115
iShares MSCI Taiwan ETF
EWT
$9.86B
| $13.5M | ﹤0.01% |
385,931
+22,434
| +6% | +$775K |
|
1116
Citizens Financial Group
CFG
$30.3B
| $13.4M | ﹤0.01% |
380,147
+172,316
| +83% | +$6.01M |
|
1117
Voyager Therapeutics
VYGR
$183M
| $13.4M | ﹤0.01% |
492,196
| – | – |
|
|
SEM
1118
DELISTED
Select Medical
SEM
| $13.3M | ﹤0.01% |
1,552,431
+19,297
| +1% | +$152K |
|
|
AFMD
1119
DELISTED
Affimed
AFMD
| $13.2M | ﹤0.01% |
461,500
-11,573
| -2% | -$390K |
|
|
KL
1120
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
| $13.2M | ﹤0.01% |
306,532
+239,899
| +360% | +$8.32M |
|
|
MRLN
1121
DELISTED
Marlin Business Services Corp
MRLN
| $13.2M | ﹤0.01% |
530,186
+4,530
| +0.9% | +$102K |
|
|
PRNB
1122
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $13.2M | ﹤0.01% |
397,865
+139,312
| +54% | +$4.35M |
|
1123
Hurco Companies Inc
HURC
$135M
| $13.2M | ﹤0.01% |
370,706
+31,406
| +9% | +$1.19M |
|
1124
Movado Group
MOV
$849M
| $13.2M | ﹤0.01% |
487,546
+337,646
| +225% | +$10.6M |
|
1125
Bruker
BRKR
$9.57B
| $13.2M | ﹤0.01% |
263,330
-59,850
| -19% | -$2.52M |
|
Similar funds
Wellington Management Group's Q2 2019 Portfolio in Review
As of Q2 2019, Wellington Management Group held 2,200 positions worth $452B, up 2.3% from $442B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Wellington Management Group's Q2 2019 filing shows 165 new, 807 increased, 919 reduced and 161 closed positions. Its largest new stake was Alcon: 13,706,926 shares worth $848M. The largest sale was DuPont de Nemours, an estimated $1.18B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 22% a quarter earlier, followed by Financials and Technology.
- Wellington Management Group's largest Q2 2019 buy was Alcon: 13,706,926 shares worth $848M.
- Wellington Management Group added most to Pfizer in Q2 2019, an estimated $2.49B increase.
- Wellington Management Group's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $1.18B.
- Wellington Management Group fully exited Zillow in Q2 2019, selling an estimated $189M.
- Wellington Management Group's ten largest holdings make up 15% of its $452B portfolio in Q2 2019.
- Wellington Management Group opened 165 new positions and closed 161 in Q2 2019.
- Wellington Management Group's portfolio value rose 2.3% quarter-over-quarter to $452B.
Based on Wellington Management Group's 13F filing for Q2 2019, filed 14 Aug 2019.